Dopaminergic Therapy for Anhedonia - 2
The study explores new treatments for people with depression who have high inflammation and can't feel pleasure, called **anhedonia**. It lasts 8 weeks and uses **L-DOPA**, a medication that helps the brain, or a placebo, which looks like the medicine but doesn't contain the active ingredient. This is a **double-blind** study, meaning neither doctors nor participants know who gets the real treatment. Seventy people aged 25-55 will participate, and the entire process, including tests and scans, will take about 10-12 weeks.
- 🕒 **Length of the Study:** 8 weeks of treatment with a total participation time of 10-12 weeks. - 🔍 **Activities:** Includes lab tests, medical checks, motivation tasks, and MRI scans. - 💊 **Medication:** Participants will receive either L-DOPA or placebo.Eligibility: Participants must be 25-55 years old, diagnosed with depression, and not currently on antidepressants. Exclusions include autoimmune diseases, certain infections, cancer history, and more. Pregnant individuals or those with specific medical conditions should not participate.
Study details
NCT06075771
Emory University
8 July 2024
Not finding the right Trial?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
FAQs
Learn more about clinical trials
What is a clinical trial?
Why should I take part in a clinical trial?
How long does a clinical trial take place?
Do I get compensated for taking part in clinical trials?
How safe are clinical trials?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.